Business Description
2seventy bio Inc
NAICS : 325412
SIC : 2834
ISIN : US9013841070
Share Class Description:
TSVT: Ordinary SharesDescription
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.78 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 1.09 | |||||
| Debt-to-EBITDA | -1.85 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -1.22 | |||||
| Beneish M-Score | -0.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -42.4 | |||||
| 3-Year EBITDA Growth Rate | 9.5 | |||||
| 3-Year EPS without NRI Growth Rate | 9.7 | |||||
| 3-Year FCF Growth Rate | 1.7 | |||||
| 3-Year Book Growth Rate | 16.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 71.54 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.93 | |||||
| 9-Day RSI | 52.01 | |||||
| 14-Day RSI | 47 | |||||
| 6-1 Month Momentum % | 7.54 | |||||
| 12-1 Month Momentum % | 166.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.95 | |||||
| Quick Ratio | 4.95 | |||||
| Cash Ratio | 4.36 | |||||
| Days Sales Outstanding | 136.5 | |||||
| Days Payable | 122.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.5 | |||||
| Shareholder Yield % | 6.86 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.03 | |||||
| Operating Margin % | -311.99 | |||||
| Net Margin % | -207.25 | |||||
| FCF Margin % | -308.85 | |||||
| ROE % | -38.37 | |||||
| ROA % | -17.26 | |||||
| ROIC % | -40.93 | |||||
| ROC (Joel Greenblatt) % | -54.53 | |||||
| ROCE % | -28.93 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.25 | |||||
| PB Ratio | 0.89 | |||||
| Price-to-Tangible-Book | 0.92 | |||||
| EV-to-EBIT | -1.72 | |||||
| EV-to-EBITDA | -1.83 | |||||
| EV-to-Forward-EBITDA | -2.04 | |||||
| EV-to-Revenue | 5.38 | |||||
| EV-to-Forward-Revenue | 2.4 | |||||
| EV-to-FCF | -1.74 | |||||
| Earnings Yield (Greenblatt) % | -58.14 | |||||
| FCF Yield % | -68.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TSVT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
2seventy bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 45.62 | ||
| EPS (TTM) ($) | -1.86 | ||
| Beta | 1.78 | ||
| Volatility % | 142.62 | ||
| 14-Day RSI | 47 | ||
| 14-Day ATR ($) | 0.295148 | ||
| 20-Day SMA ($) | 4.0475 | ||
| 12-1 Month Momentum % | 166.48 | ||
| 52-Week Range ($) | 1.675 - 6.4 | ||
| Shares Outstanding (Mil) | 51.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
2seventy bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
2seventy bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
2seventy bio Inc Frequently Asked Questions
What is 2seventy bio Inc(TSVT)'s stock price today?
The current price of TSVT is $3.96. The 52 week high of TSVT is $6.40 and 52 week low is $1.68.
When is next earnings date of 2seventy bio Inc(TSVT)?
The next earnings date of 2seventy bio Inc(TSVT) is 2025-03-05 Est..
Does 2seventy bio Inc(TSVT) pay dividends? If so, how much?
2seventy bio Inc(TSVT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers